Sign in

CIK 0000715446

  • Non-accelerated filer
  • Smaller reporting company

Anixa Biosciences Inc

Sign in to watch
Ticker
ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Oct 31
Incorporated
DE
Entity type
Operating
EIN
112622630
Phone
+1 408-708-9808
Business address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
Former names
ITUS Corp, COPYTELE INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale Vice President-Finance & CFO sold 500 shares at $3.76 ($1,880)
  4. 4 Open-market sale Vice President-Finance & CFO sold 3,500 shares at an average $3.78 ($13,234)
  5. 4 Open-market buy Director bought 5,616 shares at $4.59 ($25,777)
  6. 4 Open-market buy Director bought 1,000 shares at $4.70 ($4,700)
  7. 4 Open-market buy Director bought 1,400 shares at $4.49 ($6,286)
  8. 4 Open-market buy Director bought 700 shares at an average $4.91 ($3,437)
  9. 4 Open-market buy Director bought 100 shares at $5.15 ($515)
  10. 4 Open-market buy Director bought 681 shares at an average $5.28 ($3,598)
  11. 4 Open-market buy Director bought 600 shares at $5.62 ($3,372)
  12. 4 Open-market buy Director bought 500 shares at $4.90 ($2,450)
  13. 4 Open-market buy Director bought 300 shares at an average $5.29 ($1,588)
  14. 4 Open-market buy Director bought 600 shares at an average $4.46 ($2,673)
  15. 4 Open-market buy Director bought 2,000 shares at $3.95 ($7,900)
  16. 4 Open-market buy Director bought 2,000 shares at $4.15 ($8,300)
  17. 4 Open-market buy Director bought 300 shares at $4.66 ($1,398)
  18. 4 Open-market buy Director bought 1,700 shares at $4.49 ($7,633)
  19. 4 Open-market buy Director bought 1,500 shares at $5.23 ($7,845)
  20. 4 Open-market buy Director bought 3,050 shares at an average $5.15 ($15,704)

Page 13 of 24 · 471 filings